Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor
Citations Over TimeTop 10% of 2009 papers
Abstract
In an effort to discover novel selective monoamine oxidase (MAO) B inhibitors with favorable physicochemical and pharmacokinetic profiles, 7-[(m-halogeno)benzyloxy]coumarins bearing properly selected polar substituents at position 4 were designed, synthesized, and evaluated as MAO inhibitors. Several compounds with MAO-B inhibitory activity in the nanomolar range and excellent MAO-B selectivity (selectivity index SI > 400) were identified. Structure-affinity relationships and docking simulations provided valuable insights into the enzyme-inhibitor binding interactions at position 4, which has been poorly explored. Furthermore, computational and experimental studies led to the identification and biopharmacological characterization of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate 22b (NW-1772) as an in vitro and in vivo potent and selective MAO-B inhibitor, with rapid blood-brain barrier penetration, short-acting and reversible inhibitory activity, slight inhibition of selected cytochrome P450s, and low in vitro toxicity. On the basis of this preliminary preclinical profile, inhibitor 22b might be viewed as a promising clinical candidate for the treatment of neurodegenerative diseases.
Related Papers
- → Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients(2002)98 cited
- → Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study(1991)95 cited
- → The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues(1986)40 cited
- → Deamination of 5‐Hydroxytryptamine by Both Forms of Monoamine Oxidase in the Rat Brain(1982)126 cited
- → Inhibition of Monoamine Oxidases (MAOs) by Green Tea Extracts(2018)